Cardiac Arrhythmia Market by Segment, End-User, & Forecast to 2026

Globally, Cardiovascular diseases are the leading cause of mortality. According to the World Health Organisation, nearly 17.9 million global deaths occur due to Cardiovascular disease every year. According to the American Heart Association (AHA), more than 800 Thousand individuals die from cardiovascular diseases in the United States each year and nearly 92.1 million Americans are living with some form of cardiovascular disease. A cardiac arrhythmia is a condition where the person heartbeat is irregular, i.e., either, too slow, or too fast. Cardiac arrhythmia monitoring devices help in monitoring the patients who are at risk with heart arrhythmia. According to Renub Research Analysis, Global Cardiac Arrhythmia Market will be US$ 7.9 Billion by 2026.

What is Cardiac Arrhythmia and How Monitoring Device Helps?

People with cardiovascular diseases have increased risk of cardiac arrhythmia condition like tachycardia and bradycardia that need continuous monitoring to overcome sudden heart failure. When a heart rate is above 100 beats per minute in adults that it is called “tachycardia”. And when the heart rate of an adult is below 60 beats per minute than it is called “bradycardia”.

The cardiac arrhythmia monitoring device can monitor or record the electrical activity of the heart. These devices help in identifying the type and the cause of irregular heart rhythms. These devices help in continuously monitor the patients suffering from cardiac arrhythmia through remote patient monitoring.

Factors Driving the Cardiac Arrhythmia Market

Growth of telemedicine and the popularity of smartphone technology has changed the landscape of cardiac monitoring devices. Besides, key players operating in the market are competing based on advanced and connected cardiac arrhythmia monitoring devices which is expected to propel the growth of this market in upcoming years.

The driving force, which is boosting the global Cardiac Arrhythmia Market, is surging cases of lifestyle habits say obesity, smoking, excessive alcohol consumption. Some of the other factors include rising healthcare expenditure, rising consumption of tobacco and alcohol, accelerating economic growth, growing obese population.

Renub Research report titled “Global Cardiac Arrhythmia Market by Segment (Implantable Cardiac Monitoring Devices, ECG Testing Device, Mobile Cardiac Telemetry Monitors and Event Recorder), Region (North America (United States and Canada), Latin America, Europe, Asia Pacific and Rest of the World), End-User (Hospitals, Clinics & Cardiac Centers, Ambulatory Surgery Centers and Other End User) Key Players (Abbott Laboratories, GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Biotelemetry, Inc.)” This report provides an all-encompassing analysis on the Global cardiac arrhythmia market

Request a Free Sample Copy of the Report:

Segments – This report covers Market from 4 Viewpoints

• Implantable Cardiac Monitoring Devices
• ECG Testing Device
• Mobile Cardiac Telemetry Monitors
• Event Recorder

End – Users – Market breakup from 3 Viewpoints

• Hospitals, Clinics & Cardiac Centers
• Ambulatory Surgery Centers
• Other End-User

Regions – Market breakup from all the 5 Regions

• North America
• United States
• Canada
• Latin America
• Europe
• Asia Pacific (APAC)
• Rest of the World

All the key players have been covered from 3 Viewpoints

• Overview
• Recent Developments
• Revenue Analysis

Key Players

• Abbott Laboratories
• GE Healthcare
• Medtronic PLC
• Koninklijke Philips NV
• Biotelemetry, Inc.

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Follow on Linkedin:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s